[Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing].
Rui Jin(Capital Medical University), Dan Yan(Chemical Pharmaceutical Research Institute), Lixing Nie(National Institutes for Food and Drug Control), Jinfa Tang(Henan University of Traditional Chinese Medicine), Xingzhong Feng(Capital Medical University), Guohui Li(University of Science and Technology of China), Yi Zhang(Chinese Center For Disease Control and Prevention), Bing Zhang(Shenyang Pharmaceutical University), Yuguang Wang(Beijing Ditan Hospital), Xianglin Zhang(China-Japan Friendship Hospital), Lixia Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Kuijun Zhao(Capital Medical University), Guo Gui-ming(Capital Medical University), Yiheng Yang(Citigroup), Can Yan(Guangzhou University of Chinese Medicine), Xue Chun-Miao(Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine), Tingting Zhao(Stomatology Hospital), Yuan Suo-zhong(Capital Medical University), Lulu Sun(Capital Medical University)
Cited by 9
Related Papers
Modular Pathway Engineering of Diterpenoid Synthases and the Mevalonic Acid Pathway for Miltiradiene Production
|Journal of the American Chemical Society|2012|410
All-cause mortality risk associated with long-term exposure to ambient PM2·5 in China: a cohort study
|The Lancet Public Health|2018|301
Mining longitudinal web queries: Trends and patterns
|Journal of the American Society for Information Science and Technology|2003|175
Discovery of natural flavonoids as activators of Nrf2-mediated defense system: Structure-activity relationship and inhibition of intracellular oxidative insults
|Bioorganic & Medicinal Chemistry|2018|49
Association between insomnia and atrial fibrillation in a Chinese population: A cross‐sectional study
|Clinical Cardiology|2017|37